title: Effects of valproic acid on hearing in epileptic patients.
abstract: OBJECTIVE
  Since some case reports about the ototoxicity of valproic acid have been published, probable adverse effects of valproic acid on hearing in the epileptic patients became a subject of interest. We wanted to investigate if ototoxicity occurs in pediatric epileptic patients using VPA for long terms.
  
  
  METHODS
  Twenty-one epileptic patients who have been using valproic acid at least for 6 months as monotherapy and 21 age-sex matched controls were included in the study. Audiometric tests were performed to all patients between the frequencies of 125 and 16,000 Hz. The effects of dosage, duration of therapy and serum levels of the VPA, on the audiometric results were investigated and the audiometric results were compared between the groups.
  
  
  RESULTS
  There was no difference in hearing thresholds of the groups between 125 and 16,000 Hz frequencies. Relation could not be established between the duration of VPA therapy, dosage of the drug, blood level of drug, age and sex of the patients and the auditory signs.
  
  
  CONCLUSIONS
  Although we could not find any deleterious effect of VPA on hearing thresholds in our patient series, we think it is useful to perform audiometric tests at intervals while VPA is being used for long periods, considering the presented case reports about sensorineural hearing loss.
authors.affiliation: Mustafa Kemal University Medical Faculty, Department of Pediatrics, Hatay, Turkey. fincecik@yahoo.com
authors.forename: Faruk
authors.initials: F
authors.lastname: Incecik
authors.forename: Ertap
authors.initials: E
authors.lastname: Akoglu
authors.forename: Ozlem
authors.initials: O
authors.lastname: Sangün
authors.forename: Ismet
authors.initials: I
authors.lastname: Melek
authors.forename: Taskin
authors.initials: T
authors.lastname: Duman
mesh_terms: D000293:Adolescent; D000927:Anticonvulsants / Q000008:administration & dosage*; D001299:Audiometry; D001309:Auditory Threshold / Q000502:physiology*; D016022:Case-Control Studies; D002648:Child; D004334:Drug Administration Schedule; D004827:Epilepsy / Q000188:drug therapy / Q000503:physiopathology*; D005260:Female; D006309:Hearing / Q000502:physiology*; D006801:Humans; D008297:Male; D014635:Valproic Acid / Q000008:administration & dosage*
chemical_list: D000927:Anticonvulsants; D014635:Valproic Acid